Chennevieres sur Marne, France

Denis Bricout

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cephalon, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis Bricout. Retrieved from https://idiyas.com/inventor/denis-bricout

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Denis Bricout

Introduction

Denis Bricout is a notable inventor based in Chennevières-sur-Marne, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of proteasome inhibitors. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Denis Bricout holds a patent for "Lyophilization cakes of proteasome inhibitors." This patent describes lyophilized cakes of proteasome inhibitors, along with methods for their production and use. His innovative approach in this area has the potential to enhance the stability and efficacy of these important compounds.

Career Highlights

Bricout is associated with Cephalon, Inc., a company known for its focus on developing innovative therapies for various medical conditions. His work at Cephalon has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Denis Bricout has collaborated with esteemed colleagues, including Helene Cambourieux and Michael L. Cappola. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Denis Bricout's contributions to the field of proteasome inhibitors exemplify his commitment to innovation in pharmaceuticals. His patent and collaborative efforts highlight the importance of teamwork in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…